Individual holder
QUIMATRYX S L
ES·1 granted patent·4 pending applications·0 citations·filing 2014–2022
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
5 records- 0145US2026070895A1Crystalline formsQUIMATRYX S L·Filed 2022·Application pending·0 cites
- 0244US2025281453A1Combination therapies comprising qtx125QUIMATRYX S L·Filed 2022·Application pending·0 cites
- 0337US12202823B21,3,4-oxadiazole derivatives as histone deacetylase inhibitorsQUIMATRYX S L·Filed 2020·Granted Jan 21, 2025·0 cites·15 claims
- 0431US2016122340A1Histone deacetylase inhibitors based on derivatives of tricyclic polyhydroacridine and analogs possessing fused saturated five-and-seven-membered ringsQUIMATRYX S L·Filed 2014·Application pending·0 cites
- 0527US2019314334A1Compounds for the treatment of autoimmune diseasesQUIMATRYX S L·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when QUIMATRYX S L files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →